Literature DB >> 2461712

Activity of pentosan polysulphate and derived compounds on vascular endothelial cell proliferation and migration induced by acidic and basic FGF in vitro.

J M Herbert1, M Cottineau, F Driot, J M Pereillo, J P Maffrand.   

Abstract

Pentosan polysulphate (PPS, SP 54, HEMOCLAR), a highly sulphated semi-synthetic polysaccharide of MW 4700 Daltons is as efficient as heparin in potentiating the mitogenic activity of acidic FGF (aFGF) on human umbilical vein endothelial cells (HUVEC). When added to basic FGF (bFGF), no effect was observed on these cells. However, PPS had a strong inhibitory effect on the growth of bovine aortic endothelial cells (BAEC), as did heparin. PPS was fractionated according to molecular weight and the activities of these fractions were compared. A PPS fraction of MW = 3200 Daltons represented the critical size required to affect cell proliferation induced by FGFs. We also report that acidic and basic FGFs are both chemotactic for BAEC and HUVEC. PPS and heparin, which were chemotactic alone on BAEC, potentiated acidic FGF-induced migration but inhibited the chemotactic response of basic FGF. These data suggest that PPS, although having a different structure, can mimic the in vitro activity of heparin on FGF-induced proliferation and migration of endothelial cells and thus the possibility of a specific heparin sequence being involved in the interactions with FGFs can be questioned.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461712     DOI: 10.1016/0006-2952(88)90608-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  Antiangiogenic effect of sulphated and nonsulphated glycosaminoglycans and polysaccharides in the chick embryo chorioallantoic membrane.

Authors:  R Hahnenberger; A M Jakobson
Journal:  Glycoconj J       Date:  1991-08       Impact factor: 2.916

Review 2.  Development of angiogenesis inhibitors for cancer therapy.

Authors:  S G Eckhardt; J M Pluda
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

3.  Activation of the high affinity nerve growth factor receptor by two polyanionic chemotherapeutic agents: role in drug induced neurotoxicity.

Authors:  J S Gill; A J Windebank
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130

Review 4.  Proteoglycans and glycosaminoglycans in tumor growth and migration: first experience with tumors of bladder and prostate origin.

Authors:  D H Schamhart; K H Kurth
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 5.  Treatment of Kaposi's sarcoma. Current guidelines and future perspectives.

Authors:  D W Northfelt
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

Review 6.  Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.

Authors:  Paola Chiodelli; Antonella Bugatti; Chiara Urbinati; Marco Rusnati
Journal:  Molecules       Date:  2015-04-10       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.